In this episode, Dr. Stephen Byrn, Head of Aptuit Scientific Advisory Board, speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process.

Issues and Innovations in Drug Development presented by Aptuit

Molecular Design and the Critical Path Problem

Thank you for subscribing to our podcast series. Aptuit will continually update the series with interviews from experts across the entire drug development continuum.

About

Issues and Innovations in Drug Development presented by Aptuit